X
29Jan

UK Life Sciences and Healthcare Newsletter: Life Sciences - What's new in France? Foreign direct investment control in France in time of COVID

Dechert LLP | | Return|
To lower the risk of opportunistic trading resulting from the pandemic, the French government temporarily tightened its control over investments in strategic public companies. On 29 April 2020, the Ministry of Finance announced tighter controls over foreign investments into French companies, to protect them against opportunistic takeovers as a result of the COVID-19 pandemic....
By: Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-3513453/

Related

GMAC Urges Lawmakers to Ease Up on H-1B Restrictions

The Graduate Management Admission Council or GMAC has sent a letter to governmental leaders calling ...

Read More >

Google Partners with Theta Labs as Validator Node

As part of a multi-faceted deal, Google will become a validator node for Theta’s Mainnet 2.0. As pa...

Read More >

Get Answers To Your EEO-1 Comp Data Questions!

The EEOC has a treasure trove. Woo-hoo! The Equal Employment Opportunity Commission has just posted...

Read More >

Key Considerations in Acquisitions of Acquisitive Companies

In a market with soaring multiples, private equity buyers are increasingly on the hunt to mitigate h...

Read More >

Healthcare & Life Sciences Private Equity Deal Tracker: Thomas H. Lee Partners and Frazier Healthcare Partners Acquire Adare Pharmaceuticals

Thomas H. Lee Partners and Frazier Healthcare Partners have acquired Adare Pharmaceuticals from TPG ...

Read More >